(Q47802235)

5 February 2018

title

HER-2/neu and p53 in osteosarcoma: an immunohistochemical and fluorescence in situ hybridization analysis (English)

1 reference

5 February 2018

1 reference

James Y Tsai

1

1 reference

5 February 2018

Hana Aviv

2

1 reference

5 February 2018

Joseph Benevenia

3

1 reference

5 February 2018

Victor T Chang

4

1 reference

5 February 2018

Francis Patterson

5

1 reference

5 February 2018

Seena Aisner

6

1 reference

5 February 2018

Meera Hameed

7

1 reference

5 February 2018

publication date

1 January 2004

1 reference

5 February 2018

published in

Cancer Investigation

1 reference

5 February 2018

volume

22

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

16-24

1 reference

5 February 2018

Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Rearrangement of the p53 gene in human osteogenic sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Mechanisms of p53 loss in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

HER-2/neu amplification and overexpression in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

p53 protein accumulation and p53 gene mutation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120027577

21 January 2018

Identifiers

DOI

10.1081/CNV-120027577

1 reference

5 February 2018

1 reference

5 February 2018